Annual CFF
$724.00 K
+$489.00 K+208.09%
31 December 2023
Summary:
Design Therapeutics annual cash flow from financing activities is currently $724.00 thousand, with the most recent change of +$489.00 thousand (+208.09%) on 31 December 2023. During the last 3 years, it has fallen by -$43.81 million (-98.37%). DSGN annual CFF is now -99.81% below its all-time high of $379.21 million, reached on 31 December 2021.DSGN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1000.00
-$228.00 K-99.56%
30 September 2024
Summary:
Design Therapeutics quarterly cash flow from financing activities is currently $1000.00, with the most recent change of -$228.00 thousand (-99.56%) on 30 September 2024. Over the past year, it has dropped by -$12.00 thousand (-92.31%). DSGN quarterly CFF is now -100.00% below its all-time high of $378.98 million, reached on 31 March 2021.DSGN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$751.00 K
-$12.00 K-1.57%
30 September 2024
Summary:
Design Therapeutics TTM cash flow from financing activities is currently $751.00 thousand, with the most recent change of -$12.00 thousand (-1.57%) on 30 September 2024. Over the past year, it has increased by +$398.00 thousand (+112.75%). DSGN TTM CFF is now -99.80% below its all-time high of $379.21 million, reached on 31 December 2021.DSGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DSGN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +208.1% | -92.3% | +112.8% |
| 3 y3 years | -98.4% | -96.7% | -99.8% |
| 5 y5 years | - | - | - |
DSGN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.8% | +208.1% | -99.8% | +100.5% | -99.8% | +850.6% |
| 5 y | 5 years | -99.8% | +269.4% | -100.0% | +100.5% | -99.8% | +850.6% |
| alltime | all time | -99.8% | +269.4% | -100.0% | +100.5% | -99.8% | +850.6% |
Design Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1000.00(-99.6%) | $751.00 K(-1.6%) |
| June 2024 | - | $229.00 K(+1045.0%) | $763.00 K(+2.6%) |
| Mar 2024 | - | $20.00 K(-96.0%) | $744.00 K(+2.8%) |
| Dec 2023 | $724.00 K(+208.1%) | $501.00 K(+3753.8%) | $724.00 K(+105.1%) |
| Sept 2023 | - | $13.00 K(-93.8%) | $353.00 K(-28.1%) |
| June 2023 | - | $210.00 K(>+9900.0%) | $491.00 K(+521.5%) |
| Mar 2023 | - | $0.00(-100.0%) | $79.00 K(-66.4%) |
| Dec 2022 | $235.00 K | $130.00 K(-13.9%) | $235.00 K(-21.1%) |
| Sept 2022 | - | $151.00 K(-174.8%) | $298.00 K(+68.4%) |
| June 2022 | - | -$202.00 K(-229.5%) | $177.00 K(-53.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $156.00 K(-19.2%) | $384.00 K(-99.9%) |
| Dec 2021 | $379.21 M(+751.5%) | $193.00 K(+543.3%) | $379.21 M(+0.1%) |
| Sept 2021 | - | $30.00 K(+500.0%) | $379.02 M(+0.0%) |
| June 2021 | - | $5000.00(-100.0%) | $378.99 M(+0.0%) |
| Mar 2021 | - | $378.98 M(>+9900.0%) | $378.98 M(+751.0%) |
| Dec 2020 | $44.53 M(>+9900.0%) | $1000.00(>+9900.0%) | $44.53 M(+0.0%) |
| Sept 2020 | - | $0.00(0.0%) | $44.53 M(0.0%) |
| June 2020 | - | $0.00(-100.0%) | $44.53 M(0.0%) |
| Mar 2020 | - | $44.53 M | $44.53 M |
| Dec 2019 | $196.00 K | - | - |
FAQ
- What is Design Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Design Therapeutics?
- What is Design Therapeutics annual CFF year-on-year change?
- What is Design Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Design Therapeutics?
- What is Design Therapeutics quarterly CFF year-on-year change?
- What is Design Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Design Therapeutics?
- What is Design Therapeutics TTM CFF year-on-year change?
What is Design Therapeutics annual cash flow from financing activities?
The current annual CFF of DSGN is $724.00 K
What is the all time high annual CFF for Design Therapeutics?
Design Therapeutics all-time high annual cash flow from financing activities is $379.21 M
What is Design Therapeutics annual CFF year-on-year change?
Over the past year, DSGN annual cash flow from financing activities has changed by +$489.00 K (+208.09%)
What is Design Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of DSGN is $1000.00
What is the all time high quarterly CFF for Design Therapeutics?
Design Therapeutics all-time high quarterly cash flow from financing activities is $378.98 M
What is Design Therapeutics quarterly CFF year-on-year change?
Over the past year, DSGN quarterly cash flow from financing activities has changed by -$12.00 K (-92.31%)
What is Design Therapeutics TTM cash flow from financing activities?
The current TTM CFF of DSGN is $751.00 K
What is the all time high TTM CFF for Design Therapeutics?
Design Therapeutics all-time high TTM cash flow from financing activities is $379.21 M
What is Design Therapeutics TTM CFF year-on-year change?
Over the past year, DSGN TTM cash flow from financing activities has changed by +$398.00 K (+112.75%)